TG Therapeutics Inc. (TGTX) NASDAQ

$27 0.51 (1.93%)

Market Cap: $3.96B

As of 06/07/23 04:00 PM EDT. Market closed.

(TGTX)

TG Therapeutics Inc. (TGTX)
NASDAQ

$27
0.51 (1.93%)

Market Cap: $3.96B

As of 06/07/23 04:00 PM EDT. Market closed.

TG Therapeutics is a fully-integrated, commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. In addition to an active research pipeline including five investigational medicines across these therapeutic areas, TG has received accelerated approval from the U.S. FDA for UKONIQTM ... read more

TG Therapeutics is a fully-integrated, commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. In addition to an active research pipeline including five investigational medicines across these therapeutic areas, TG has received accelerated approval from the U.S. FDA for UKONIQTM (umbralisib), for the treatment of adult patients with relapsed/refractory marginal zone lymphoma who have received at least one prior anti-CD20-based regimen and relapsed/refractory follicular lymphoma who have received at least three prior lines of systemic therapies. Currently, the Company has two programs in Phase 3 development for the treatment of patients with relapsing forms of multiple sclerosis (RMS) and patients with chronic lymphocytic leukemia (CLL) and several investigational medicines in Phase 1 clinical development. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Weiss
Full Time Employees
286
CEO Compensation (Base)
$655,625
CEO Compensation (Total)
$14.30M
URL
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Michael Weiss
Full Time Employees
286
CEO Compensation (Base)
$655,625
CEO Compensation (Total)
$14.30M
Address
2 Gansevoort St Fl 9, New York, New York, 10014-1667.
PRICE CHART FOR TG THERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$26.57
Previous Close
$26.49
Days Range
$25.71 - $27.73
52 week range
$3.48 - $35.67
Volume
3,244,263
Avg. Volume (30 days)
3,324,665
Market Cap
$3.96B
Dividend Yield
0.00%
P/E
-23.48
Shares Outstanding
149,396,038
Open
$26.57
Previous Close
$26.49
Days Range
$25.71 - $27.73
52 week range
$3.48 - $35.67
Volume
3,244,263
Avg. Volume (30 days)
3,324,665
Market Cap
$3.96B
Dividend Yield
0.00%
P/E
-23.48
Shares Outstanding
149,396,038

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR TG THERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Power Sean AChief Financial OfficerJun 02, 2023 Sale$26.7073,6471,966,375654,836Jun 05, 2023, 06:26 PM
Echelard YannDirectorJan 06, 2023 Buy$10.649,00095,760201,848Jan 06, 2023, 05:01 PM
Charney Laurence NDirectorJan 04, 2023 Sale$11.1030,000333,000234,729Jan 06, 2023, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2022 Sale$18.319,653176,746568,483Jan 07, 2022, 06:11 PM
Power Sean ACFO, Secretary and TreasurerJan 04, 2022 Sale$19.2075,3121,445,990578,136Jan 07, 2022, 06:11 PM
WEISS MICHAEL SCEO and PresidentJan 05, 2022 Sale$18.3130,671561,58610,988,021Jan 07, 2022, 06:00 PM
WEISS MICHAEL SCEO and PresidentJan 04, 2022 Sale$19.2037,549720,94113,455,697Jan 07, 2022, 06:00 PM
Echelard YannDirectorDec 10, 2020 Sale$40.0530,0001,201,500129,116Dec 11, 2020, 05:01 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerSep 09, 2020 Sale$25.81158,5894,092,73812,629,868Sep 11, 2020, 04:31 PM
KENNEDY WILLIAM JAMESDirectorJun 17, 2020 Sale$18.277,745141,50194,633Jun 24, 2020, 07:48 PM
Power Sean ACFO, Secretary and TreasurerJul 01, 2019 Sale$8.4717,654149,529383,338Jul 03, 2019, 04:00 PM
WEISS MICHAEL SCEO and PresidentJun 26, 2019 Buy$7.0350,000351,75012,878,185Jun 27, 2019, 07:33 AM
Power Sean ACFO, Secretary and TreasurerJan 02, 2019 Sale$4.1337,275153,946400,992Jan 03, 2019, 07:21 PM
Power Sean ACFO, Secretary and TreasurerJul 02, 2018 Sale$13.2612,191161,653473,267Jul 05, 2018, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJul 03, 2018 Sale$13.1935,000461,650438,267Jul 05, 2018, 05:00 PM
KENNEDY WILLIAM JAMESDirectorJun 14, 2018 Sale$13.4525,071337,20560,330Jun 18, 2018, 04:30 PM
Power Sean ACFO, Secretary and TreasurerJan 02, 2018 Sale$8.5032,006272,051485,458Jan 03, 2018, 05:25 PM
Power Sean ACFO, Secretary and TreasurerJun 19, 2017 Sale$11.0430,000331,200447,464Jun 19, 2017, 06:05 PM
Power Sean ACFO, Secretary and TreasurerJun 16, 2017 Sale$11.1429,976333,933477,464Jun 19, 2017, 06:05 PM
KENNEDY WILLIAM JAMESDirectorApr 11, 2017 Sale$10.278,54887,78870,401Apr 12, 2017, 05:44 PM
Charney Laurence NDirectorApr 04, 2017 Sale$11.177,00078,19088,949Apr 04, 2017, 05:57 PM
Power Sean ACFO, Secretary and TreasurerJan 04, 2017 Sale$4.558,81640,113507,440Jan 04, 2017, 05:28 PM
Power Sean ACFO, Secretary and TreasurerJul 05, 2016 Sale$5.9950,426302,052416,256Jul 08, 2016, 08:06 PM
Power Sean ACFO, Secretary and TreasurerApr 18, 2016 Sale$10.1210,000101,200466,682Apr 20, 2016, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2016 Sale$11.2122,790255,476476,682Jan 07, 2016, 06:00 PM
KENNEDY WILLIAM JAMESDirectorJul 08, 2015 Sale$17.0817,000290,36066,490Jul 09, 2015, 09:41 PM
Power Sean ACFO, Secretary and TreasurerJul 01, 2015 Sale$16.4650,054823,889449,472Jul 02, 2015, 05:00 PM
LFB Biotechnologies S.A.S.U.10% OwnerFeb 17, 2015 Buy$6.53114,855750,0035,114,855May 11, 2015, 04:30 PM
LFB Biotechnologies S.A.S.U.10% OwnerMay 07, 2015 Option Exercise$0.002,500,0002,5007,614,855May 11, 2015, 04:30 PM
Power Sean ACFO, Secretary and TreasurerApr 02, 2015 Sale$15.5111,000170,610499,526Apr 03, 2015, 05:00 PM
Power Sean ACFO, Secretary and TreasurerApr 01, 2015 Sale$15.5012,800198,400510,526Apr 03, 2015, 05:00 PM
Power Sean ACFO, Secretary and TreasurerJan 05, 2015 Sale$16.4054,057886,448535,670Jan 07, 2015, 08:50 PM
Power Sean ACFO, Secretary and TreasurerJan 07, 2015 Sale$16.4012,344202,442523,326Jan 07, 2015, 08:50 PM
WEISS MICHAEL SSee RemarksDec 16, 2014 Sale$16.44210,6183,462,5608,120,773Dec 18, 2014, 09:44 PM
Power Sean ACFO, Secretary and TreasurerDec 16, 2014 Sale$16.4438,041625,394579,727Dec 18, 2014, 09:37 PM
Power Sean ACFO, Secretary and TreasurerNov 21, 2013 Option Exercise$5.3823,106124,310542,768Jan 02, 2014, 07:00 PM
WEISS MICHAEL SSee RemarksDec 11, 2013 Buy$3.4310,00034,3007,839,471Dec 12, 2013, 06:06 AM
Power Sean ACFO, Secretary and TreasurerMay 17, 2012 Option Exercise$6.2513,52684,538490,874Jan 02, 2013, 08:11 PM
Herskowitz NeilDirectorDec 06, 2012 Buy$2.001,0002,00051,265Dec 12, 2012, 04:30 PM
Power Sean ACFO, Secretary and TreasurerSep 14, 2012 Buy$2.283,4007,752504,400Sep 17, 2012, 09:46 AM
Power Sean ACFO, Secretary and TreasurerSep 13, 2012 Buy$2.251,0002,250501,000Sep 17, 2012, 09:46 AM
WEISS MICHAEL SSee RemarksSep 11, 2012 Buy$2.25100,000225,0007,342,728Sep 11, 2012, 04:01 PM
WEISS MICHAEL SSee RemarksSep 10, 2012 Buy$2.2550,000112,5007,242,728Sep 11, 2012, 04:01 PM
WEISS MICHAEL SSee RemarksMay 16, 2012 Buy$6.251,5009,3755,192,728May 17, 2012, 05:32 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Power Sean AChief Financial Officer06/02/20231,966,375
Echelard YannDirector01/06/202395,760
Charney Laurence NDirector01/04/2023333,000
Power Sean ACFO, Secretary and Treasurer01/05/2022176,746
Power Sean ACFO, Secretary and Treasurer01/04/20221,445,990
WEISS MICHAEL SCEO and President01/05/2022561,586
WEISS MICHAEL SCEO and President01/04/2022720,941
Echelard YannDirector12/10/20201,201,500
RA CAPITAL MANAGEMENT, L.P.10% Owner09/09/20204,092,738
KENNEDY WILLIAM JAMESDirector06/17/2020141,501
Power Sean ACFO, Secretary and Treasurer07/01/2019149,529
WEISS MICHAEL SCEO and President06/26/2019351,750
Power Sean ACFO, Secretary and Treasurer01/02/2019153,946
Power Sean ACFO, Secretary and Treasurer07/02/2018161,653
Power Sean ACFO, Secretary and Treasurer07/03/2018461,650
KENNEDY WILLIAM JAMESDirector06/14/2018337,205
Power Sean ACFO, Secretary and Treasurer01/02/2018272,051
Power Sean ACFO, Secretary and Treasurer06/19/2017331,200
Power Sean ACFO, Secretary and Treasurer06/16/2017333,933
KENNEDY WILLIAM JAMESDirector04/11/201787,788
Charney Laurence NDirector04/04/201778,190
Power Sean ACFO, Secretary and Treasurer01/04/201740,113
Power Sean ACFO, Secretary and Treasurer07/05/2016302,052
Power Sean ACFO, Secretary and Treasurer04/18/2016101,200
Power Sean ACFO, Secretary and Treasurer01/05/2016255,476
KENNEDY WILLIAM JAMESDirector07/08/2015290,360
Power Sean ACFO, Secretary and Treasurer07/01/2015823,889
LFB Biotechnologies S.A.S.U.10% Owner02/17/2015750,003
LFB Biotechnologies S.A.S.U.10% Owner05/07/20152,500
Power Sean ACFO, Secretary and Treasurer04/02/2015170,610
Power Sean ACFO, Secretary and Treasurer04/01/2015198,400
Power Sean ACFO, Secretary and Treasurer01/05/2015886,448
Power Sean ACFO, Secretary and Treasurer01/07/2015202,442
WEISS MICHAEL SSee Remarks12/16/20143,462,560
Power Sean ACFO, Secretary and Treasurer12/16/2014625,394
Power Sean ACFO, Secretary and Treasurer11/21/2013124,310
WEISS MICHAEL SSee Remarks12/11/201334,300
Power Sean ACFO, Secretary and Treasurer05/17/201284,538
Herskowitz NeilDirector12/06/20122,000
Power Sean ACFO, Secretary and Treasurer09/14/20127,752
Power Sean ACFO, Secretary and Treasurer09/13/20122,250
WEISS MICHAEL SSee Remarks09/11/2012225,000
WEISS MICHAEL SSee Remarks09/10/2012112,500
WEISS MICHAEL SSee Remarks05/16/20129,375
Load More Insider Transactions
FUNDS WITH A POSITION IN TG THERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.8,849,7000.00393%-3.11%Other
MAVERICK CAPITAL LTD4,318,7001.21%ExitedGrowth At A Reasonable Price, Growth
GEODE CAPITAL MANAGEMENT, LLC2,679,8000.00523%3.62%Other
D. E. SHAW & CO., INC.833,7770.01%-62.17%Other
DRIEHAUS CAPITAL MANAGEMENT LLC847,7440.18%NewGrowth
BALYASNY ASSET MANAGEMENT L.P.355,2480.01%NewEvent Driven
GOTHAM ASSET MANAGEMENT, LLC120,8870.04%-4.39%Other
RENAISSANCE TECHNOLOGIES LLC99,1000.0016%ExitedOther
AQR CAPITAL MANAGEMENT LLC43,3770.00143%NewOther
DUPONT CAPITAL MANAGEMENT CORP18,8890.01%ExitedOther
MAGNETAR FINANCIAL LLC12,6950.00372%NewEvent Driven, Other
ALPINE GLOBAL MANAGEMENT, LLC11,5780.05%ExitedEvent Driven
CHANGE IN SHARES OUTSTANDING FOR TG THERAPEUTICS INC
STOCK BUYBACKS FOR TG THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2023
12/31/2022
3.62%
1Q
03/31/2023
09/30/2022
4.06%
2Q
03/31/2023
03/31/2022
4.40%
4Q
03/31/2023
12/31/2021
6.12%
5Q
03/31/2023
09/30/2021
6.21%
6Q
03/31/2023
06/30/2021
6.31%
7Q
03/31/2023
03/31/2021
6.38%
8Q
03/31/2023
09/30/2020
24.85%
10Q
03/31/2023
06/30/2020
28.81%
11Q
03/31/2023
03/31/2020
33.05%
12Q
Load More

Period of Report: 03/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2022
3.62%
1Q
09/30/2022
4.06%
2Q
03/31/2022
4.40%
4Q
12/31/2021
6.12%
5Q
09/30/2021
6.21%
6Q
06/30/2021
6.31%
7Q
03/31/2021
6.38%
8Q
09/30/2020
24.85%
10Q
06/30/2020
28.81%
11Q
03/31/2020
33.05%
12Q
Load More